Copyright
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 7, 2019; 25(5): 608-621
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.608
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.608
Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years
Dong Kyun Kim, Yang Hyun Baek, Department of Internal Medicine, Dong-A University College of Medicine, Busan 49201, South Korea
Bo Ra Kim, Department of Radiology, Dong-A University College of Medicine, Busan 49201, South Korea
Jin Sook Jeong, Department of Pathology, Dong-A University College of Medicine, Busan 49201, South Korea
Author contributions: Kim DK is the first author, designed the study, collected and analyzed the data, and drafted the manuscript; Kim BR helped in analyzing the findings of the imaging studies; Jeong JS helped in analyzing the histopathologic findings of the biopsies; Baek YH designed and supervised the study and revised the manuscript for important intellectual content; All authors have read and approved the final version of the manuscript to be published.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Dong-A University Hospital.
Informed consent statement: Patients were not required to provide an informed consent for the study because the analysis used anonymous clinical data that were obtained after the completion of treatment.
Conflict-of-interest statement: All authors declare no conflicts of interest related to this article.
Data sharing statement: No additional data are available.
Open-Access: This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Yang Hyun Baek, MD, PhD, Associate Professor, Department of Internal Medicine, Dong-A University College of Medicine, 26 Daesingongwon-ro, Seo-gu, Busan 49201, South Korea. p100100@dau.ac.kr
Telephone: +82-51-2405678 Fax: +82-51-2401510
Received: October 31, 2018
Peer-review started: October 31, 2018
First decision: December 20, 2018
Revised: January 3, 2019
Accepted: January 14, 2019
Article in press: January 14, 2019
Published online: February 7, 2019
Processing time: 91 Days and 6.4 Hours
Peer-review started: October 31, 2018
First decision: December 20, 2018
Revised: January 3, 2019
Accepted: January 14, 2019
Article in press: January 14, 2019
Published online: February 7, 2019
Processing time: 91 Days and 6.4 Hours
Core Tip
Core tip: Intrahepatic sarcomatoid cholangiocarcinoma is rare condition. Patients usually present with an advanced stage of the disease, and they have a poor prognosis. Diagnosis based on histopathologic examination is important because serologic and radiologic examinations cannot help in distinguishing such condition from intrahepatic bile duct adenocarcinoma or other intrahepatic masses. Thus, patients must be diagnosed as early as possible and should receive aggressive treatment, including surgical resection.